Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1456 | Thyroid (non-cancer) | ECE2017

Anaplastic thyroid carcinoma and multinodular toxic goiter

Capraru Oana-Maria

A 69 years old female with cervical radiotherapy 25 years ago for an unknown condition, known with multinodular goitre and hyperthyroidism for 6 years, presented with a 6 months history of enlarged right supraclavicular mass, local pain with difficulty in mobilization of the right arm and weight loss. She also reported progressive bilateral exophtalmia especially on the right side, no dysphagia, hoarseness or dyspnoea. Thyroid hormone levels were normal on antithyroid drugs an...

ea0032p1125 | Thyroid cancer | ECE2013

Coexistent medullary thyroid carcinoma and multifocal papillary thyroid microcarcinoma in a patient with chronic autoimmune thyroiditis

Pascanu Ionela , Neagoe Radu , Capraru Oana , Borda Angela

Introduction: The association between medullary (MTC) and differentiated thyroid cancer (DTC, with the most frequent form of papillary thyroid carcinoma, PTC) is rare and can be observed in two main settings: a collision tumor (that is, a tumor with two separate and different components) or a mixed tumor showing dual differentiation.Case report: A 58-year-old woman, affected by euthyroid multinodular goiter came to our observation for a second opinion re...

ea0041oc13.4 | Pituitary Clinical | ECE2016

Diagnosis and management of thyrotropin-secreting pituitary tumors: a single center experience with a long-term follow-up of 30 patients

Capraru Oana-Maria , Gaillard Celine , Vasiljevic Alexandre , Raverot Veronique , Borson-Chazot Francoise , Jouanneau Emmanuel , Raverot Gerald

TSH secreting pituitary adenomas are rare tumours for which the treatment of choice is neurosurgery but in some cases medical treatment with somatostatin analogs (SSA) can lead to a good control of symptoms and shrinkage of the tumour.The objective of this study was to review 30 patients diagnosed with TSH-omas between October 1981–July 2014, followed-up for a median of 43.93 months (1.12–192.11) in our University Hospital from Lyon, France.</p...

ea0056gp206 | Pituitary Clinical | ECE2018

Clinicopathological correlations in pituitary thyrotroph tumors from a cohort of 23 patients

Capraru Oana-Maria , Vasiljevic Alexandre , Gaillard Celine , Borson-Chazot Francoise , Raverot Veronique , Jouanneau Emmanuel , Trouillas Jacqueline , Raverot Gerald

The thyrotroph tumors or pituitary neuroendocrine tumors (PitNET) classify as tumors of Pit-1 family. These tumors are rare and may be monohormonal, secreting only TSH, or plurihormonal, secreting TSH-GH±PRL, with or without acromegaly. The objectives of this retrospective study were to confirm the frequency of the plurihormonal subtype and to compare the clinical, biological and pathological characteristics of these two pathological subtypes. We retrospectively studied t...

ea0041gp235 | Thyroid Cancer (1) | ECE2016

Thyroid nodules: a highly specific molecular and cytological combined predictor of malignancy

Lasolle Helene , Riche Benjamin , Decaussin Myriam , Dantony Emmanuelle , Cornu Catherine , Lifante Jean-Christophe , Capraru Oana-Maria , Rousset Bernard , Borson-Chazot Francoise , Roy Pascal

Thyroid nodules are very common and benign in most cases. Thus, malignancy detection avoiding overtreatment is a challenge. Nodule evaluation mainly supports on US and fine needle aspiration cytology (FNAC). The Bethesda classification (BC) for reporting thyroid cytopathology is now currently used for the interpretation of results but it does not enable classifying 30% of samples.The objective was to identify, by transcriptome analysis, a molecular signa...